vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Shutterstock, Inc. (SSTK). Click either name above to swap in a different company.

Shutterstock, Inc. is the larger business by last-quarter revenue ($220.2M vs $164.7M, roughly 1.3× PTC THERAPEUTICS, INC.). Shutterstock, Inc. runs the higher net margin — -7.3% vs -82.0%, a 74.7% gap on every dollar of revenue. On growth, Shutterstock, Inc. posted the faster year-over-year revenue change (-12.0% vs -22.7%). Shutterstock, Inc. produced more free cash flow last quarter ($25.9M vs $-36.6M). Over the past eight quarters, Shutterstock, Inc.'s revenue compounded faster (1.4% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Shutterstock, Inc. is an American provider of stock photography, stock footage, stock music, and editing tools; it is headquartered in New York. Founded in 2002 by programmer and photographer Jon Oringer, Shutterstock maintains a library of around 200 million royalty-free stock photos, vector graphics, and illustrations, with around 10 million video clips and music tracks available for licensing. Originally a subscription site only, Shutterstock expanded beyond subscriptions into à la carte p...

PTCT vs SSTK — Head-to-Head

Bigger by revenue
SSTK
SSTK
1.3× larger
SSTK
$220.2M
$164.7M
PTCT
Growing faster (revenue YoY)
SSTK
SSTK
+10.7% gap
SSTK
-12.0%
-22.7%
PTCT
Higher net margin
SSTK
SSTK
74.7% more per $
SSTK
-7.3%
-82.0%
PTCT
More free cash flow
SSTK
SSTK
$62.5M more FCF
SSTK
$25.9M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
SSTK
SSTK
Annualised
SSTK
1.4%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
SSTK
SSTK
Revenue
$164.7M
$220.2M
Net Profit
$-135.0M
$-16.0M
Gross Margin
55.8%
Operating Margin
-43.3%
-1.1%
Net Margin
-82.0%
-7.3%
Revenue YoY
-22.7%
-12.0%
Net Profit YoY
-104.8%
-1021.0%
EPS (diluted)
$-1.63
$-0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
SSTK
SSTK
Q4 25
$164.7M
$220.2M
Q3 25
$211.0M
$260.1M
Q2 25
$178.9M
$267.0M
Q1 25
$1.2B
$242.6M
Q4 24
$213.2M
$250.3M
Q3 24
$196.8M
$250.6M
Q2 24
$186.7M
$220.1M
Q1 24
$210.1M
$214.3M
Net Profit
PTCT
PTCT
SSTK
SSTK
Q4 25
$-135.0M
$-16.0M
Q3 25
$15.9M
$13.4M
Q2 25
$-64.8M
$29.4M
Q1 25
$866.6M
$18.7M
Q4 24
$-65.9M
$-1.4M
Q3 24
$-106.7M
$17.6M
Q2 24
$-99.2M
$3.6M
Q1 24
$-91.6M
$16.1M
Gross Margin
PTCT
PTCT
SSTK
SSTK
Q4 25
55.8%
Q3 25
60.6%
Q2 25
60.3%
Q1 25
58.4%
Q4 24
55.1%
Q3 24
58.3%
Q2 24
58.5%
Q1 24
58.8%
Operating Margin
PTCT
PTCT
SSTK
SSTK
Q4 25
-43.3%
-1.1%
Q3 25
1.4%
12.5%
Q2 25
-19.5%
13.0%
Q1 25
82.5%
4.2%
Q4 24
-76.2%
5.3%
Q3 24
-27.7%
7.2%
Q2 24
-21.5%
9.4%
Q1 24
-21.6%
7.8%
Net Margin
PTCT
PTCT
SSTK
SSTK
Q4 25
-82.0%
-7.3%
Q3 25
7.5%
5.1%
Q2 25
-36.3%
11.0%
Q1 25
73.7%
7.7%
Q4 24
-30.9%
-0.6%
Q3 24
-54.2%
7.0%
Q2 24
-53.1%
1.6%
Q1 24
-43.6%
7.5%
EPS (diluted)
PTCT
PTCT
SSTK
SSTK
Q4 25
$-1.63
$-0.47
Q3 25
$0.20
$0.37
Q2 25
$-0.83
$0.82
Q1 25
$10.04
$0.53
Q4 24
$-0.85
$-0.04
Q3 24
$-1.39
$0.50
Q2 24
$-1.29
$0.10
Q1 24
$-1.20
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
SSTK
SSTK
Cash + ST InvestmentsLiquidity on hand
$1.9B
$178.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$581.0M
Total Assets
$2.9B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
SSTK
SSTK
Q4 25
$1.9B
$178.2M
Q3 25
$1.7B
$165.5M
Q2 25
$2.0B
$116.4M
Q1 25
$2.0B
$112.2M
Q4 24
$1.1B
$111.3M
Q3 24
$1.0B
$131.4M
Q2 24
$1.1B
$74.9M
Q1 24
$884.8M
$71.8M
Stockholders' Equity
PTCT
PTCT
SSTK
SSTK
Q4 25
$-205.3M
$581.0M
Q3 25
$-155.8M
$594.4M
Q2 25
$-206.5M
$586.2M
Q1 25
$-185.8M
$547.2M
Q4 24
$-1.1B
$518.4M
Q3 24
$-1.1B
$522.9M
Q2 24
$-980.2M
$520.4M
Q1 24
$-893.9M
$541.3M
Total Assets
PTCT
PTCT
SSTK
SSTK
Q4 25
$2.9B
$1.4B
Q3 25
$2.6B
$1.4B
Q2 25
$2.6B
$1.4B
Q1 25
$2.7B
$1.3B
Q4 24
$1.7B
$1.3B
Q3 24
$1.8B
$1.3B
Q2 24
$1.9B
$1.0B
Q1 24
$1.8B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
SSTK
SSTK
Operating Cash FlowLast quarter
$-34.3M
$36.2M
Free Cash FlowOCF − Capex
$-36.6M
$25.9M
FCF MarginFCF / Revenue
-22.3%
11.8%
Capex IntensityCapex / Revenue
1.4%
4.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$123.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
SSTK
SSTK
Q4 25
$-34.3M
$36.2M
Q3 25
$-66.3M
$78.4M
Q2 25
$-58.3M
$26.8M
Q1 25
$870.1M
$25.2M
Q4 24
$-30.0M
$8.0M
Q3 24
$-77.0M
$-11.6M
Q2 24
$-71.5M
$28.0M
Q1 24
$70.8M
$8.3M
Free Cash Flow
PTCT
PTCT
SSTK
SSTK
Q4 25
$-36.6M
$25.9M
Q3 25
$-69.7M
$68.0M
Q2 25
$-59.6M
$15.5M
Q1 25
$868.4M
$14.4M
Q4 24
$-33.8M
$-952.0K
Q3 24
$-77.5M
$-26.3M
Q2 24
$-78.8M
$18.9M
Q1 24
$61.2M
$-6.2M
FCF Margin
PTCT
PTCT
SSTK
SSTK
Q4 25
-22.3%
11.8%
Q3 25
-33.1%
26.1%
Q2 25
-33.3%
5.8%
Q1 25
73.8%
6.0%
Q4 24
-15.8%
-0.4%
Q3 24
-39.4%
-10.5%
Q2 24
-42.2%
8.6%
Q1 24
29.1%
-2.9%
Capex Intensity
PTCT
PTCT
SSTK
SSTK
Q4 25
1.4%
4.7%
Q3 25
1.6%
4.0%
Q2 25
0.7%
4.2%
Q1 25
0.1%
4.5%
Q4 24
1.8%
3.6%
Q3 24
0.3%
5.9%
Q2 24
4.0%
4.1%
Q1 24
4.6%
6.7%
Cash Conversion
PTCT
PTCT
SSTK
SSTK
Q4 25
Q3 25
-4.17×
5.86×
Q2 25
0.91×
Q1 25
1.00×
1.35×
Q4 24
Q3 24
-0.66×
Q2 24
7.71×
Q1 24
0.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons